Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.
Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.
Safeway on Monday announced that its month-long prostate cancer campaign raised nearly $10.1 million as part of the company’s ongoing effort to fund research geared toward finding a cure for the leading cancer affecting men.
The Colon Cancer Alliance’s Denver Undy 5000 5K run held at City Park last month had more than 1,300 people wearing underwear, boxer shorts or silly costumes helping to bring greater awareness to colon cancer, the second-leading cause of cancer death in the United States.
To celebrate Men's Health Month, Sam's Club is offering free men's health screening tests this weekend at select stores, which will be sponsored by Unilever brands, including Dove Men's deodorant and body wash.
Despite the promise of oral drugs for treating cancer, high costs and the burden of taking multiple medications drive 10% of patients prescribed the drugs not to fill their initial prescriptions, according to a new study published in the Journal of Oncology Practice and the American Journal of Managed Care.
A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.
An investigational drug helped patients survive longer when combined with chemotherapy as a second-line treatment for colorectal cancer that had spread to other parts of the body, according to results of a late-stage clinical trial announced by French drug maker Sanofi-Aventis and U.S.-based Regeneron Pharmaceuticals.
Breast cancer survivors who experience large weight gain have an increased risk of death after diagnosis, according to research released Tuesday by scientists at the Kaiser Permanente Division of Research in Oakland, Calif.
To help promote the third annual St. Louis Undy 5000 5K run on March 26, the Colon Cancer Alliance is introducing the “Parade of Undies” fashion show, sponsored by Boehringer Ingelheim, the maker of Dulcolax products.
March is National Colorectal Cancer Awareness Month. In support of that, Boehringer Ingelheim’s Dulcolax brand this year has partnered with the Colon Cancer Alliance. Following is CCA’s CEO Andrew Spiegel on that partnership: